AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35060336 — intervention group
Group type: COMPARATOR
Intervention: Assessment only condition (control)
Number of subjects: 386
Study 34336070 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (C‐TENS)
Number of subjects: 60
Study 34336070 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation treatment
Number of subjects: 60
Study 34247263 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic acid (ZOL) 5 mg intravenous infusion once yearly for 2 years
Number of subjects: 330
Study 32076362 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderation-based alcohol treatment with naltrexone and Modified Behavioral Self-Control Training
Number of subjects: 178
Study 35180190 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketone monoester (KME; 0.5 g·kg‐1)
Number of subjects: 14
Study 35180190 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 14
Study 34862881 — intervention group
Group type: EXPERIMENTAL
Intervention: MDD group
Number of subjects: 61
Study 34862881 — intervention group
Group type: COMPARATOR
Intervention: Healthy group
Number of subjects: 61
Study 34261858 — intervention group
Group type: EXPERIMENTAL
Intervention: Eflornithine (750 mg) + Sulindac (150 mg)
Number of subjects: 158
Study 34261858 — intervention group
Group type: COMPARATOR
Intervention: Sulindac (150 mg)
Number of subjects: 158
Study 34261858 — intervention group
Group type: COMPARATOR
Intervention: Eflornithine (750 mg)
Number of subjects: 158
Study 33737440 — intervention group
Group type: EXPERIMENTAL
Intervention: self‐aligning prosthetic ankle‐foot
Number of subjects: 55
Study 33737440 — intervention group
Group type: COMPARATOR
Intervention: non‐self‐aligning ankle‐foot
Number of subjects: 55
Study 32357133 — intervention group
Group type: EXPERIMENTAL
Intervention: AI-BR model (machine learning model)
Number of subjects: 15603
Study 32357133 — intervention group
Group type: COMPARATOR
Intervention: ACC-BR model (American College of Cardiology CathPCI bleeding risk model)
Number of subjects: 15603
Study 32357133 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall cohort
Number of subjects: 15603
Study 33465015 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal plasma ferritin at gestational week 30 (GW30)
Number of subjects: 573
Study 33465015 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal plasma ferritin at gestational week 14 (GW14)
Number of subjects: 573
Study 33465015 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal plasma ferritin
Number of subjects: 573
Study 32915063 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibacterial envelope (TYRX) adjunctive to standard-of-care infection prevention
Number of subjects: 6983
Study 32915063 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care infection prevention
Number of subjects: 6983
Study 36216962 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium intake >7 servings
Number of subjects: 496
Study 36216962 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D intake >7 servings
Number of subjects: 496
Study 36216962 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity ≥2.5 hours
Number of subjects: 496
Study 36216962 — intervention group
Group type: EXPERIMENTAL
Intervention: Body fat association with lumbar spine BMD
Number of subjects: 496
Study 33957257 — intervention group
Group type: EXPERIMENTAL
Intervention: ATLS Training
Number of subjects: 1030
Study 35452339 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS with anode over the right cerebellum (O2) and cathode over the supplementary motor area (pre-SMA; c3/c4)
Number of subjects: 40
Study 35452339 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS with anode over O2 and cathode over the left OFC (FP1)
Number of subjects: 40
Study 35452339 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS with anode over O2 and cathode over the left cerebellum (O1)
Number of subjects: 40
Study 35452339 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation (anode over O2 and cathode over the left FP1)
Number of subjects: 40
Study 35501751 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous tranexamic acid (15 mg/kg before incision and 1 mg/kg/hour during operation)
Number of subjects: 68
Study 35501751 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo: 0.9% sodium chloride solution)
Number of subjects: 68
Study 32367879 — intervention group
Group type: EXPERIMENTAL
Intervention: 17% EDTA
Number of subjects: 45
Study 32367879 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% chitosan
Number of subjects: 45
Study 32367879 — intervention group
Group type: COMPARATOR
Intervention: 10% trisodium citrate
Number of subjects: 45
Study 34029605 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorsal onlay urethroplasty
Number of subjects: 24
Study 34029605 — intervention group
Group type: COMPARATOR
Intervention: Ventral onlay urethroplasty
Number of subjects: 24
Study 33962567 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged TV viewing time (≥4 h/day)
Number of subjects: 2752
Study 33962567 — intervention group
Group type: EXPERIMENTAL
Intervention: Not working
Number of subjects: 2752
Study 33962567 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower education attainment
Number of subjects: 2752
Study 33962567 — intervention group
Group type: EXPERIMENTAL
Intervention: Living status
Number of subjects: 2752
Study 33962567 — intervention group
Group type: EXPERIMENTAL
Intervention: EHE
Number of subjects: 2752
Study 32201056 — intervention group
Group type: EXPERIMENTAL
Intervention: Spherical silicone hydrogel contact lenses (comfilcon A)
Number of subjects: 68
Study 32201056 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspheric silicone hydrogel contact lenses (comfilcon A)
Number of subjects: 68
Study 32201056 — intervention group
Group type: COMPARATOR
Intervention: Comparison between spherical and aspheric lenses
Number of subjects: 68
Study 34374961 — intervention group
Group type: EXPERIMENTAL
Intervention: LDP + NPX (carbidopa/levodopa and naproxen)
Number of subjects: 72
Study 34374961 — intervention group
Group type: COMPARATOR
Intervention: Placebo + naproxen
Number of subjects: 72
Study 34374961 — intervention group
Group type: EXPERIMENTAL
Intervention: LDP + NPX
Number of subjects: 72
Study 35092886 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-based intervention (PBI) with alcohol-related content; n = 44
Number of subjects: 82
Study 35092886 — intervention group
Group type: COMPARATOR
Intervention: Parent-based intervention (PBI) without alcohol-related content; n = 38
Number of subjects: 82
Study 35092886 — intervention group
Group type: EXPERIMENTAL
Intervention: Living with parents
Number of subjects: 82
Study 35092886 — intervention group
Group type: EXPERIMENTAL
Intervention: Moving out of parents' home
Number of subjects: 82
Study 33828046 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised ground‐based walking training, performed two to three times/week, for 8‐10 weeks.
Number of subjects: 77
Study 33828046 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-training ESWT at a faster walking speed.
Number of subjects: 77
Study 35500978 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional physiotherapy + PNF exercises (n = 15)
Number of subjects: 44
Study 35500978 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional physiotherapy + SM techniques (n = 15)
Number of subjects: 44
Study 35500978 — intervention group
Group type: COMPARATOR
Intervention: Conventional physiotherapy (control group; n = 14)
Number of subjects: 44
Study 33143502 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet transfusion directed at platelet dysfunction
Number of subjects: 348
Study 33143502 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet functional assays
Number of subjects: 348
Study 616117228 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab
Number of subjects: 1185
Study 616117228 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 1185
Study 35108463 — intervention group
Group type: EXPERIMENTAL
Intervention: Music intervention (n=35)
Number of subjects: 70
Study 35108463 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=35)
Number of subjects: 70
Study 33838518 — intervention group
Group type: EXPERIMENTAL
Intervention: Amisulpride
Number of subjects: 288
Study 33838518 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuation of amisulpride
Number of subjects: 288
Study 33838518 — intervention group
Group type: COMPARATOR
Intervention: Switch to olanzapine
Number of subjects: 288
Study 36062851 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab (1200 mg every 21 days for 16 cycles or 1 year)
Number of subjects: 149
Study 36062851 — intervention group
Group type: COMPARATOR
Intervention: Atezolizumab
Number of subjects: 149
Study 34909951 — intervention group
Group type: COMPARATOR
Intervention: Oxybutynin 5 mg/day (Group O)
Number of subjects: 0
Study 34909951 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirabegron 50 mg/day (Group M)
Number of subjects: 0
Study 35920129 — intervention group
Group type: EXPERIMENTAL
Intervention: Test group 2 (RMNES at the same time as HBOT)
Number of subjects: 120
Study 35920129 — intervention group
Group type: EXPERIMENTAL
Intervention: Test group 1 (RMNES after HBOT)
Number of subjects: 120
Study 35920129 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study 35920129 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (EEG, BAEP, USEP)
Number of subjects: 120
Study 33688992 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone-hydrocoated ureteral stents (Coloplast Imajin® hydro)
Number of subjects: 141
Study 33688992 — intervention group
Group type: COMPARATOR
Intervention: Percuflex™ Plus stent (Boston Scientific)
Number of subjects: 141
Study 32316957 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-led school-based walking intervention (10-15 min walks led by older female pupils before school, at break, and lunch for a minimum of 20-22 weeks)
Number of subjects: 18
Study 32316957 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-led school-based walking intervention
Number of subjects: 18
Study 33517316 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (NAC) with anthracycline followed by paclitaxel, RDI ≥85%
Number of subjects: 188
Study 33517316 — intervention group
Group type: COMPARATOR
Intervention: Neoadjuvant chemotherapy (NAC) with anthracycline followed by paclitaxel, RDI <85%
Number of subjects: 188
Study 32410260 — intervention group
Group type: EXPERIMENTAL
Intervention: PRIMA‐PI high-risk group
Number of subjects: 291
Study 32410260 — intervention group
Group type: COMPARATOR
Intervention: FLIPI risk groups
Number of subjects: 291
Study 32410260 — intervention group
Group type: EXPERIMENTAL
Intervention: PRIMA‐PI
Number of subjects: 291
Study 35286033 — intervention group
Group type: EXPERIMENTAL
Intervention: melatonin 5mg/kg/day per gastric tube for 3 days
Number of subjects: 80
Study 35286033 — intervention group
Group type: COMPARATOR
Intervention: surfactant with the INSURE technique
Number of subjects: 80
Study 35668430 — intervention group
Group type: EXPERIMENTAL
Intervention: self‐efficacy‐enhancing physical activity intervention
Number of subjects: 244
Study 35668430 — intervention group
Group type: COMPARATOR
Intervention: usual care
Number of subjects: 244
Study 33071237 — intervention group
Group type: EXPERIMENTAL
Intervention: PRT + metformin (metPRT)
Number of subjects: 47
Study 33071237 — intervention group
Group type: COMPARATOR
Intervention: PRT with placebo (plaPRT)
Number of subjects: 47
Study 34902765 — intervention group
Group type: EXPERIMENTAL
Intervention: Palbociclib plus Fulvestrant
Number of subjects: 190
Study 34902765 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus Fulvestrant
Number of subjects: 190
Study 35614158 — intervention group
Group type: EXPERIMENTAL
Intervention: One preoperative showering with CHG 4% (Group B)
Number of subjects: 45
Study 35614158 — intervention group
Group type: EXPERIMENTAL
Intervention: Two preoperative showering with CHG 4% (Group C)
Number of subjects: 45
Study 35614158 — intervention group
Group type: COMPARATOR
Intervention: No preoperative showering (Group A)
Number of subjects: 45
Study 35614158 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of skin concentration at different sites
Number of subjects: 45
Study 33153986 — intervention group
Group type: EXPERIMENTAL
Intervention: Completion of PROMs at home (paper-and-pencil format)
Number of subjects: 93
Study 33153986 — intervention group
Group type: COMPARATOR
Intervention: Completion of PROMs at hospital
Number of subjects: 93
Study 33153986 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall preference for completion method
Number of subjects: 93
Study 36315523 — intervention group
Group type: EXPERIMENTAL
Intervention: i-MaCHeL intervention programme (classroom activities for children and web-based educational programme for parents)
Number of subjects: 460
Study 36315523 — intervention group
Group type: COMPARATOR
Intervention: Control group (existing health-related activities for children and general health newsletters for parents)
Number of subjects: 460
Study 32895969 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-delivered, protein-rich meal service (6 protein-rich dishes per day for 3 weeks)
Number of subjects: 126
Study 32895969 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 126
Study 35079806 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrient compendium snacks containing ≥5 g fiber, 1000 mg ω‐3 fatty acids, 1000 mg phytosterols, and 1800 μmol antioxidants per serving.
Number of subjects: 54
Study 35079806 — intervention group
Group type: COMPARATOR
Intervention: Control products (calorie-matched like-items from the general grocery marketplace).
Number of subjects: 54
Study 35079806 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrient compendium snacks
Number of subjects: 54
Study 34399585 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive drug classes
Number of subjects: 0
Study 34399585 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid-lowering drug classes
Number of subjects: 0
Study 34399585 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticoagulant drug classes
Number of subjects: 0
Study 34399585 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel drug targets for inflammatory pathways
Number of subjects: 0
Study 34399585 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel drug targets for coagulation cascade
Number of subjects: 0
Study 34707169 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy intervention aimed at strengthening muscles and improving prosthesis adaptation.
Number of subjects: 26
Study 34707169 — intervention group
Group type: COMPARATOR
Intervention: Control group (participants with amputation who did not receive the intervention).
Number of subjects: 26
Study 33408462 — intervention group
Group type: EXPERIMENTAL
Intervention: Half-dose triple combination (amlodipine 2.5 mg + losartan 25 mg + chlorthalidone 6.25 mg)
Number of subjects: 248
Study 33408462 — intervention group
Group type: EXPERIMENTAL
Intervention: Third-dose triple combination (amlodipine 1.67 mg + losartan 16.67 mg + chlorthalidone 4.17 mg)
Number of subjects: 248
Study 33408462 — intervention group
Group type: EXPERIMENTAL
Intervention: Quarter-dose triple combination (amlodipine 1.25 mg + losartan 12.5 mg + chlorthalidone 3.13 mg)
Number of subjects: 248
Study 33408462 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine 10 mg
Number of subjects: 248
Study 33408462 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine 5 mg
Number of subjects: 248
Study 33408462 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan 100 mg
Number of subjects: 248
Study 33408462 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 248
Study 35835521 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft palatal augmentation prosthesis (PAP)
Number of subjects: 0
Study 35835521 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation using soft PAP
Number of subjects: 0
Study 35835521 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation without soft PAP
Number of subjects: 0
Study 33745452 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin glue (1 cc of IFABOND® applied to the surgical bed)
Number of subjects: 80
Study 33745452 — intervention group
Group type: COMPARATOR
Intervention: Control group (no fibrin glue)
Number of subjects: 80
Study 32616256 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal diet with 2-fold supplementation level of water-soluble vitamins (WV)
Number of subjects: 300
Study 32616256 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal diet with 2-fold supplementation level of lipid-soluble vitamins (LV)
Number of subjects: 300
Study 32616256 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal diet with 2-fold supplementation level of both lipid-soluble and water-soluble vitamins (BV)
Number of subjects: 300
Study 32616256 — intervention group
Group type: COMPARATOR
Intervention: Basal diet (CON)
Number of subjects: 300
Study 35604794 — intervention group
Group type: COMPARATOR
Intervention: Masked continuous glucose monitoring (CGM) over 14 days during baseline
Number of subjects: 288
Study 35604794 — intervention group
Group type: EXPERIMENTAL
Intervention: Open continuous glucose monitoring (CGM) over 14 days after randomization
Number of subjects: 288
Study 35604794 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall diagnostic performance of hypoglycemic parameters
Number of subjects: 288
Study 33985848 — intervention group
Group type: EXPERIMENTAL
Intervention: Orogastric intubation (OGI)
Number of subjects: 12
Study 33985848 — intervention group
Group type: COMPARATOR
Intervention: Nasogastric intubation (NGI)
Number of subjects: 12
Study 35050357 — intervention group
Group type: COMPARATOR
Intervention: In-person DOT
Number of subjects: 216
Study 35050357 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic DOT
Number of subjects: 216
Study 33647172 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive management with coronary angiography (CA)
Number of subjects: 1052
Study 33647172 — intervention group
Group type: COMPARATOR
Intervention: Conservative management
Number of subjects: 1052
Study 33647172 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive management
Number of subjects: 1052
Study 32928328 — intervention group
Group type: EXPERIMENTAL
Intervention: CarbonCool cooling vest
Number of subjects: 23
Study 32928328 — intervention group
Group type: COMPARATOR
Intervention: Control group (no cooling vest)
Number of subjects: 23
Study 36246973 — intervention group
Group type: EXPERIMENTAL
Intervention: Ankle muscle strength training for 6 weeks
Number of subjects: 16
Study 36246973 — intervention group
Group type: COMPARATOR
Intervention: Ankle muscle strength training and ankle proprioception training
Number of subjects: 16
Study 33927176 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive Group (saline hydration given 6 h before until 12 h after the procedure)
Number of subjects: 144
Study 33927176 — intervention group
Group type: EXPERIMENTAL
Intervention: Remedial Group (saline hydration given after procedure for 12 h)
Number of subjects: 144
Study 33927176 — intervention group
Group type: COMPARATOR
Intervention: No Hydration (NH) Group (saline given only during the procedure)
Number of subjects: 144
Study 33927176 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive Group
Number of subjects: 144
Study 33927176 — intervention group
Group type: EXPERIMENTAL
Intervention: Remedial Group
Number of subjects: 144
Study 33927176 — intervention group
Group type: COMPARATOR
Intervention: No Hydration (NH) Group
Number of subjects: 144
Study 33008699 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-dimensional printed ear splint therapy
Number of subjects: 0
Study 33008699 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 35332042 — intervention group
Group type: EXPERIMENTAL
Intervention: Intelligent system evaluation for gait disorders
Number of subjects: 0
Study 35332042 — intervention group
Group type: COMPARATOR
Intervention: Clinicians' routine treatment procedures
Number of subjects: 0
Study 32829596 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug therapy combined with vestibular rehabilitation training (Experimental group)
Number of subjects: 43
Study 32829596 — intervention group
Group type: COMPARATOR
Intervention: Drug therapy (Control group)
Number of subjects: 43
Study 35987698 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal therapy (HFNT)
Number of subjects: 850
Study 35987698 — intervention group
Group type: COMPARATOR
Intervention: Standard oxygen therapy (SOT)
Number of subjects: 850
Study 32453885 — intervention group
Group type: EXPERIMENTAL
Intervention: Covariate-adaptive randomization (CAR)
Number of subjects: 0
Study 32453885 — intervention group
Group type: EXPERIMENTAL
Intervention: Covariate-adaptive randomization (CAR) with misclassified covariates adjusted in the model
Number of subjects: 0
Study 32453885 — intervention group
Group type: COMPARATOR
Intervention: Two sample t-test
Number of subjects: 0
Study 35287487 — intervention group
Group type: EXPERIMENTAL
Intervention: Managing Fatigue: Individual Program (MFIP) delivered via videoconference
Number of subjects: 54
Study 35287487 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 54
Study 32295565 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline as adjunctive treatment
Number of subjects: 100
Study 32295565 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 100
Study 35472112 — intervention group
Group type: EXPERIMENTAL
Intervention: BC combined with Emdogain (EMD+BC)
Number of subjects: 21
Study 35472112 — intervention group
Group type: EXPERIMENTAL
Intervention: Alloplastic bone substitute (BoneCeramic [BC])
Number of subjects: 21
Study 35472112 — intervention group
Group type: COMPARATOR
Intervention: Spontaneous healing (SO)
Number of subjects: 21
Study 35044568 — intervention group
Group type: EXPERIMENTAL
Intervention: Asian insulin-naïve participants
Number of subjects: 4750
Study 35044568 — intervention group
Group type: EXPERIMENTAL
Intervention: Asian insulin-experienced participants
Number of subjects: 4750
Study 33799486 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquamin®
Number of subjects: 30
Study 33799486 — intervention group
Group type: COMPARATOR
Intervention: Calcium alone
Number of subjects: 30
Study 33799486 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 32175973 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training
Number of subjects: 185
Study 32175973 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined training
Number of subjects: 185